A Pfizer Document the FDA Tried to Hide Shows LNPs from COVID-19 Vaccine Travel Everywhere in the Body

It’s very bad to have LNP in the liver, ovaries, spleen, and more...

When the Covid-19 vaccines rolled out, public health officials took great pains to downplay how the vaccines spread from the injection site. Articles with language like this were common: “Most of the mRNA vaccine stayed in the injection site muscle—where you get the shot.”

We now know the truth. The lipid nanoparticles, or LNPs, travel widely throughout the body. These LNPs carry the Frankenstein mRNA that causes the cells to produce spike proteins.

We initially got tissue biodistribution data from Japan which showed that significant lipid concentrations were found in the adrenal glands, bone marrow, liver, ovaries, spleen (and more) for at least 48 hours after injection:

Then we saw the same study data show up in a document from the Australian Department of Health:

And from the lawsuit that we brought against the FDA demanding the release of the Pfizer documents, we now know that this same data was also provided to the FDA. What is really troubling, however, is that this document was dated November 9, 2020—meaning, prior to any Emergency Use Authorization or public use of Pfizer’s Covid-19 vaccine.

Having LNPs release their cargo into the cells of critical organs is very concerning. This is because many scientists will tell you that the spike protein produces an immune response, including inflammation. It is one thing to have inflammation in one’s bicep, but it is quite another to have it in your heart muscle, liver, ovaries, etc.

This is again why the government should not be in the business of promoting, let alone mandating, any product. It becomes impossible to acknowledge safety issues without self-incrimination. How often do you hear the government say, “Oops, you know that thing we told every American to inject into their body? Well, it actually can cause serious harm to...

Read More HERE